Agios Pharmaceuticals
AGIO
#3539
Rank
โ‚น259.08 B
Marketcap
โ‚น4,543
Share price
-2.92%
Change (1 day)
143.05%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2024 (TTM): โ‚น2.44 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น2.48 Billion. In 2023 the company made a revenue of โ‚น2.23 Billion an increase over the revenue in the year 2022 that were of โ‚น1.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น2.44 B9.29%
2023 โ‚น2.23 B89.5%
2022 โ‚น1.17 B
2021 N/A-100%
2020 โ‚น3.22 B-61.69%
2019 โ‚น8.40 B27.4%
2018 โ‚น6.59 B140.32%
2017 โ‚น2.74 B-42.18%
2016 โ‚น4.74 B20.89%
2015 โ‚น3.92 B-5.15%
2014 โ‚น4.14 B162.44%
2013 โ‚น1.57 B14.82%
2012 โ‚น1.37 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น11.28 B 354.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น175.84 B 6,979.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.700 T 189,139.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น232.54 B 9,262.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.400 T 136,800.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น3.451 T 138,876.64%๐Ÿ‡บ๐Ÿ‡ธ USA